Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	allyl-alcohol dehydrogenase activity	AKR1B10 AKR1B15 AKR1A1	2.03e-07	4	75	3	GO:0047655
GeneOntologyMolecularFunction	aldose reductase (NADPH) activity	AKR1B10 AKR1B15 AKR1A1	1.80e-05	14	75	3	GO:0004032
GeneOntologyMolecularFunction	icosanoid binding	CYP4F8 OXER1 CYP4F12	2.75e-05	16	75	3	GO:0050542
GeneOntologyMolecularFunction	indanol dehydrogenase activity	AKR1B10 AKR1B15	8.31e-05	4	75	2	GO:0047718
GeneOntologyMolecularFunction	alpha-tocopherol omega-hydroxylase activity	CYP4F8 CYP4F12	1.38e-04	5	75	2	GO:0052871
GeneOntologyMolecularFunction	alcohol dehydrogenase (NADP+) activity	AKR1B10 AKR1B15 AKR1A1	1.40e-04	27	75	3	GO:0008106
GeneOntologyMolecularFunction	long-chain fatty acid binding	CYP4F8 OXER1 CYP4F12	1.56e-04	28	75	3	GO:0036041
GeneOntologyMolecularFunction	geranylgeranyl reductase activity	AKR1B10 AKR1B15	2.07e-04	6	75	2	GO:0045550
GeneOntologyMolecularFunction	aldo-keto reductase (NADPH) activity	AKR1B10 AKR1B15 AKR1A1	2.33e-04	32	75	3	GO:0004033
GeneOntologyMolecularFunction	leukotriene-B4 20-monooxygenase activity	CYP4F8 CYP4F12	2.89e-04	7	75	2	GO:0050051
GeneOntologyMolecularFunction	alkane 1-monooxygenase activity	CYP4F8 CYP4F12	2.89e-04	7	75	2	GO:0018685
GeneOntologyMolecularFunction	NADP+ binding	AKR1B10 AKR1B15	4.93e-04	9	75	2	GO:0070401
GeneOntologyMolecularFunction	arachidonate omega-hydroxylase activity	CYP4F8 CYP4F12	6.14e-04	10	75	2	GO:0052869
GeneOntologyMolecularFunction	fatty acid omega-hydroxylase activity	CYP4F8 CYP4F12	6.14e-04	10	75	2	GO:0120250
GeneOntologyMolecularFunction	long-chain fatty acid omega-hydroxylase activity	CYP4F8 CYP4F12	6.14e-04	10	75	2	GO:0102033
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen	CYP4F8 CYP4F12	1.06e-03	13	75	2	GO:0016713
GeneOntologyMolecularFunction	peptide hormone binding	GIPR PIK3R1 HCRTR2	1.16e-03	55	75	3	GO:0017046
GeneOntologyMolecularFunction	retinal dehydrogenase activity	AKR1B10 AKR1B15	1.23e-03	14	75	2	GO:0001758
GeneOntologyMolecularFunction	arachidonate binding	CYP4F8 CYP4F12	1.42e-03	15	75	2	GO:0050544
GeneOntologyMolecularFunction	all-trans-retinol dehydrogenase (NADP+) activity	AKR1B10 AKR1B15	1.42e-03	15	75	2	GO:0052650
GeneOntologyMolecularFunction	icosatetraenoic acid binding	CYP4F8 CYP4F12	1.61e-03	16	75	2	GO:0050543
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH2 DNAH9	2.05e-03	18	75	2	GO:0008569
GeneOntologyMolecularFunction	fatty acid binding	CYP4F8 OXER1 CYP4F12	2.23e-03	69	75	3	GO:0005504
GeneOntologyMolecularFunction	estradiol 17-beta-dehydrogenase [NAD(P)+] activity	AKR1B10 AKR1B15	2.53e-03	20	75	2	GO:0004303
GeneOntologyMolecularFunction	phosphatidylcholine transporter activity	PITPNM2 ATP8B1	2.53e-03	20	75	2	GO:0008525
GeneOntologyMolecularFunction	phospholipid transporter activity	PITPNM2 ATG9B ATP8B1	2.72e-03	74	75	3	GO:0005548
GeneOntologyMolecularFunction	retinal binding	AKR1B10 AKR1B15	2.79e-03	21	75	2	GO:0016918
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP4F8 CYP4F12	3.64e-03	24	75	2	GO:0008392
GeneOntologyMolecularFunction	lipid binding	PITPNM2 CYP4F8 OXER1 PEBP1 AKR1B10 ATG2B AKR1B15 CYP4F12 ATP8B1 INPP4B	3.75e-03	988	75	10	GO:0008289
GeneOntologyMolecularFunction	NADPH binding	AKR1B10 AKR1B15	4.27e-03	26	75	2	GO:0070402
GeneOntologyMolecularFunction	arachidonate monooxygenase activity	CYP4F8 CYP4F12	4.60e-03	27	75	2	GO:0008391
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate phosphatase activity	MTMR1 INPP4B	4.60e-03	27	75	2	GO:0034593
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH2 DNAH9	4.94e-03	28	75	2	GO:0051959
GeneOntologyMolecularFunction	phosphatidylinositol phosphate phosphatase activity	MTMR1 INPP4B	5.66e-03	30	75	2	GO:0052866
GeneOntologyMolecularFunction	lipid transporter activity	PITPNM2 ATG9B ATG2B ATP8B1	6.36e-03	196	75	4	GO:0005319
GeneOntologyMolecularFunction	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	AKR1B10 AKR1B15	6.82e-03	33	75	2	GO:0033764
GeneOntologyMolecularFunction	hormone binding	GIPR PIK3R1 HCRTR2	6.88e-03	103	75	3	GO:0042562
GeneOntologyMolecularFunction	monocarboxylic acid binding	CYP4F8 OXER1 CYP4F12	7.64e-03	107	75	3	GO:0033293
GeneOntologyMolecularFunction	aromatase activity	CYP4F8 CYP4F12	7.64e-03	35	75	2	GO:0070330
GeneOntologyBiologicalProcess	organic hydroxy compound metabolic process	CYP4F8 LMF1 ACLY ALG9 AKR1B10 AKR1B15 LSS SMPD1 CYP4F12 ATP8B1 AKR1A1 INPP4B	3.20e-06	641	75	12	GO:1901615
GeneOntologyBiologicalProcess	alcohol metabolic process	LMF1 ACLY ALG9 AKR1B10 AKR1B15 LSS SMPD1 AKR1A1 INPP4B	1.82e-05	412	75	9	GO:0006066
GeneOntologyBiologicalProcess	lipid biosynthetic process	PITPNM2 PIGT DHH ACLY PIK3R1 AKR1B15 PEX5 MTMR1 LSS SMPD1 HACD2 INPP4B	3.45e-05	813	75	12	GO:0008610
GeneOntologyCellularComponent	endoplasmic reticulum membrane	ATG9B CYP4F8 PIGT THADA LMF1 DHH RHBDF2 PIK3R1 VPS13C ALG9 ATG2B LSS CYP4F12 HACD2 CLSTN1 RNF139	7.71e-06	1293	73	16	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	ATG9B CYP4F8 PIGT THADA LMF1 DHH RHBDF2 PIK3R1 VPS13C ALG9 ATG2B LSS CYP4F12 HACD2 CLSTN1 RNF139	8.17e-06	1299	73	16	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	ATG9B CYP4F8 PIGT THADA LMF1 DHH RHBDF2 PIK3R1 VPS13C ALG9 ATG2B LSS CYP4F12 HACD2 CLSTN1 RNF139	1.07e-05	1327	73	16	GO:0042175
GeneOntologyCellularComponent	lipid droplet	VPS13C ATG2B LSS SMPD1	7.30e-04	116	73	4	GO:0005811
Domain	ALDOKETO_REDUCTASE_1	AKR1B10 AKR1B15 AKR1A1	7.31e-06	10	75	3	PS00798
Domain	Aldo/ket_reductase_CS	AKR1B10 AKR1B15 AKR1A1	7.31e-06	10	75	3	IPR018170
Domain	Aldo/keto_reductase	AKR1B10 AKR1B15 AKR1A1	7.31e-06	10	75	3	IPR020471
Domain	ALDOKETO_REDUCTASE_2	AKR1B10 AKR1B15 AKR1A1	7.31e-06	10	75	3	PS00062
Domain	ALDOKETO_REDUCTASE_3	AKR1B10 AKR1B15 AKR1A1	7.31e-06	10	75	3	PS00063
Domain	ATPase_dyneun-rel_AAA	VWA8 DNAH2 DNAH9	2.19e-05	14	75	3	IPR011704
Domain	AAA_5	VWA8 DNAH2 DNAH9	2.19e-05	14	75	3	PF07728
Domain	-	AKR1B10 AKR1B15 AKR1A1	3.35e-05	16	75	3	3.20.20.100
Domain	NADP_OxRdtase_dom	AKR1B10 AKR1B15 AKR1A1	4.06e-05	17	75	3	IPR023210
Domain	Aldo_ket_red	AKR1B10 AKR1B15 AKR1A1	4.06e-05	17	75	3	PF00248
Domain	Aldo/ket_red/Kv-b	AKR1B10 AKR1B15 AKR1A1	4.06e-05	17	75	3	IPR001395
Domain	-	PEBP1 MRPL38	4.76e-05	3	75	2	3.90.280.10
Domain	PBP	PEBP1 MRPL38	4.76e-05	3	75	2	PF01161
Domain	PEBP	PEBP1 MRPL38	4.76e-05	3	75	2	IPR008914
Domain	ATG_C	VPS13C ATG2B	1.58e-04	5	75	2	PF09333
Domain	Autophagy-rel_C	VPS13C ATG2B	1.58e-04	5	75	2	IPR015412
Domain	VPS13_N	VPS13C ATG2B	4.39e-04	8	75	2	IPR026854
Domain	Chorein_N	VPS13C ATG2B	4.39e-04	8	75	2	PF12624
Domain	DHC_N1	DNAH2 DNAH9	4.39e-04	8	75	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH2 DNAH9	4.39e-04	8	75	2	IPR013594
Domain	TPR_REGION	TTC21B DNAH2 PEX5 PRMT9 ZFC3H1	5.31e-04	165	75	5	PS50293
Domain	TPR	TTC21B DNAH2 PEX5 PRMT9 ZFC3H1	5.31e-04	165	75	5	PS50005
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH9	1.40e-03	14	75	2	IPR024317
Domain	Dynein_HC_stalk	DNAH2 DNAH9	1.40e-03	14	75	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH2 DNAH9	1.40e-03	14	75	2	IPR013602
Domain	DHC_N2	DNAH2 DNAH9	1.40e-03	14	75	2	PF08393
Domain	MT	DNAH2 DNAH9	1.40e-03	14	75	2	PF12777
Domain	AAA_8	DNAH2 DNAH9	1.40e-03	14	75	2	PF12780
Domain	DHC_fam	DNAH2 DNAH9	1.62e-03	15	75	2	IPR026983
Domain	Dynein_heavy_dom	DNAH2 DNAH9	1.62e-03	15	75	2	IPR004273
Domain	Dynein_heavy	DNAH2 DNAH9	1.62e-03	15	75	2	PF03028
Domain	MAM_1	MAMDC2 PTPRT	1.84e-03	16	75	2	PS00740
Domain	MAM	MAMDC2 PTPRT	2.08e-03	17	75	2	SM00137
Domain	MAM	MAMDC2 PTPRT	2.34e-03	18	75	2	PF00629
Domain	MAM_dom	MAMDC2 PTPRT	2.34e-03	18	75	2	IPR000998
Domain	MAM_2	MAMDC2 PTPRT	2.34e-03	18	75	2	PS50060
Domain	TPR-contain_dom	TTC21B PEX5 PRMT9 ZFC3H1	3.12e-03	150	75	4	IPR013026
Pathway	REACTOME_CALNEXIN_CALRETICULIN_CYCLE	EDEM3 GANAB UGGT2 RNF139	3.36e-06	26	57	4	M907
Pathway	REACTOME_METABOLISM_OF_LIPIDS	PITPNM2 CYP4F8 ACLY PIK3R1 AKR1B10 AKR1B15 MTMR1 LSS SMPD1 CYP4F12 HACD2 INPP4B	5.41e-06	620	57	12	MM15193
Pathway	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE	EDEM3 GANAB UGGT2 RNF139	1.15e-05	35	57	4	M918
Pathway	REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC	EDEM3 UGGT2 RNF139	7.92e-05	21	57	3	M27875
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	ANKRD13A URB1 THADA GANAB ACLY DNAH2 UGGT2 LSS QRICH1 HACD2 CLSTN1 SYMPK	7.92e-07	942	75	12	31073040
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	IGBP1 SLC4A7 GANAB ALG9 PAFAH1B2 NARS1 XPO4 LSS SMPD1 QRICH1 HACD2 RNF139 BIRC6 SOD2	8.23e-07	1327	75	14	32694731
Pubmed	Getting in and out from calnexin/calreticulin cycles.	EDEM3 GANAB UGGT2	2.71e-06	13	75	3	18303019
Pubmed	Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse.	AKR1B10 AKR1B15	4.59e-06	2	75	2	34954342
Pubmed	Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.	AKR1B10 AKR1B15	4.59e-06	2	75	2	25120755
Pubmed	Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.	AKR1B10 AKR1B15	4.59e-06	2	75	2	21087085
Pubmed	Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland.	AKR1B10 AKR1B15	4.59e-06	2	75	2	8526877
Pubmed	AKR1B8 deficiency drives severe DSS-induced acute colitis through invasion of luminal bacteria and activation of innate immunity.	AKR1B10 AKR1B15	4.59e-06	2	75	2	36518763
Pubmed	Proline-rich tyrosine kinase 2 controls PI3-kinase activation downstream of the T cell antigen receptor in human T cells.	PTK2B PIK3R1	4.59e-06	2	75	2	25387834
Pubmed	Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8.	CYP4F8 CYP4F12	4.59e-06	2	75	2	16112640
Pubmed	1.7 A structure of FR-1, a fibroblast growth factor-induced member of the aldo-keto reductase family, complexed with coenzyme and inhibitor.	AKR1B10 AKR1B15	4.59e-06	2	75	2	7578036
Pubmed	Characterization of the promoter of the gene for a mouse vas deferens protein related to the aldo-keto reductase superfamily: effect of steroid hormones and phorbol esters.	AKR1B10 AKR1B15	4.59e-06	2	75	2	8541228
Pubmed	Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice.	AKR1B10 AKR1B15	4.59e-06	2	75	2	33644071
Pubmed	Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon-gamma-induced polypeptides that includes manganese-superoxide dismutase and the p85beta subunit of phosphatidylinositol 3-kinase.	PIK3R1 SOD2	4.59e-06	2	75	2	12644569
Pubmed	Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.	AKR1B10 AKR1B15	4.59e-06	2	75	2	25538260
Pubmed	Functional expression of novel human and murine AKR1B genes.	AKR1B10 AKR1B15	4.59e-06	2	75	2	21276782
Pubmed	Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis.	AKR1B10 AKR1B15	4.59e-06	2	75	2	31911858
Pubmed	Thrombin-stimulated phosphatidylinositol 3-kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation independent.	PTK2B PIK3R1	4.59e-06	2	75	2	10797305
Pubmed	Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma.	ATG9B AKR1A1 SOD2	7.68e-06	18	75	3	19423521
Pubmed	The inositol polyphosphate 4-phosphatase forms a complex with phosphatidylinositol 3-kinase in human platelet cytosol.	PIK3R1 INPP4B	1.37e-05	3	75	2	10097090
Pubmed	Pertussis toxin promotes macrophage survival through inhibition of acid sphingomyelinase and activation of the phosphoinositide 3-kinase/protein kinase B pathway.	PIK3R1 SMPD1	1.37e-05	3	75	2	17521884
Pubmed	Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.	AKR1B10 AKR1B15	1.37e-05	3	75	2	17381426
Pubmed	Phosphatidylinositol-3-kinase activation mediates proline-rich tyrosine kinase 2 phosphorylation and recruitment to beta1-integrins in human CD34+ cells.	PTK2B PIK3R1	1.37e-05	3	75	2	15539082
Pubmed	A newly isolated Pex7-binding, atypical PTS2 protein P7BP2 is a novel dynein-type AAA+ protein.	VWA8 PEX5	1.37e-05	3	75	2	30204880
Pubmed	A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase.	AKR1B10 AKR1B15	1.37e-05	3	75	2	7510692
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	URB1 THADA SLC4A7 GANAB VWA8 PIK3R1 TUBGCP3 MTMR1 UGGT2 LSS MRPL38 ZFC3H1 THOC5	1.62e-05	1487	75	13	33957083
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	THADA SLC4A7 GANAB VWA8 PEBP1 PIK3R1 VPS13C SUPV3L1 ATG2B PEX5 MRPL38 BIRC6 YARS1	1.72e-05	1496	75	13	32877691
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ANKRD13A PIGT THADA PIK3R1 PAFAH1B2 ATG2B TTC21B XPO4 UGGT2 MRPL38 HACD2 INVS	2.45e-05	1321	75	12	27173435
Pubmed	Aberrant methylation of ATG2B, ATG4D, ATG9A and ATG9B CpG island promoter is associated with decreased mRNA expression in sporadic breast carcinoma.	ATG9B ATG2B	2.75e-05	4	75	2	27265029
Pubmed	Disruption of mouse cytochrome p450 4f14 (Cyp4f14 gene) causes severe perturbations in vitamin E metabolism.	CYP4F8 CYP4F12	2.75e-05	4	75	2	22665481
Pubmed	Genetic variants in GCKR, GIPR, ADCY5 and VPS13C and the risk of severe sulfonylurea-induced hypoglycaemia in patients with type 2 diabetes.	GIPR VPS13C	2.75e-05	4	75	2	22956255
Pubmed	Effects of genetic variants in ADCY5, GIPR, GCKR and VPS13C on early impairment of glucose and insulin metabolism in children.	GIPR VPS13C	2.75e-05	4	75	2	21789219
Pubmed	Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14.	CYP4F8 CYP4F12	2.75e-05	4	75	2	11185557
Pubmed	Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.	PIK3R1 NARS1	2.75e-05	4	75	2	19631775
Pubmed	Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein.	PITPNM2 PTK2B	2.75e-05	4	75	2	10022914
Pubmed	Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability.	ATG9B ATG2B	2.75e-05	4	75	2	19197948
Pubmed	Identification of genes and networks driving cardiovascular and metabolic phenotypes in a mouse F2 intercross.	AKR1B10 AKR1B15	2.75e-05	4	75	2	21179467
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	EDEM3 LMF1 SLC4A7 VPS13C ALG9 PEX5 UGGT2 BIRC6 STRIP2	2.84e-05	733	75	9	34672954
Pubmed	Disruption of P450-mediated vitamin E hydroxylase activities alters vitamin E status in tocopherol supplemented mice and reveals extra-hepatic vitamin E metabolism.	CYP4F8 CYP4F12	4.57e-05	5	75	2	22969154
Pubmed	Comparisons of genomic structures and chromosomal locations of the mouse aldose reductase and aldose reductase-like genes.	AKR1B10 AKR1B15	4.57e-05	5	75	2	10092857
Pubmed	Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation.	CYP4F8 CYP4F12	4.57e-05	5	75	2	21466787
Pubmed	Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans.	ATG9B ATG2B	4.57e-05	5	75	2	22710871
Pubmed	Butylated hydroxyanisole induces distinct expression patterns of Nrf2 and detoxification enzymes in the liver and small intestine of C57BL/6 mice.	AKR1B10 AKR1B15	4.57e-05	5	75	2	26291391
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EDEM3 PIGT THADA GANAB ACLY ALG9 UGGT2 SMPD1 HACD2 CLSTN1 SYMPK	5.15e-05	1201	75	11	35696571
Pubmed	Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.	GIPR VPS13C	6.84e-05	6	75	2	20081857
Pubmed	The cytochrome P450 4 (CYP4) family.	CYP4F8 CYP4F12	6.84e-05	6	75	2	9068972
Pubmed	Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain.	MTMR1 THOC5 SYMPK	8.32e-05	39	75	3	22802532
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	CYP4F8 PIGT THADA RHBDF2 UGGT2 LSS ATP8B1 AKR1A1 HACD2 SYMPK	9.20e-05	1061	75	10	33845483
Pubmed	Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).	PEX5 SOD2	9.57e-05	7	75	2	11583975
Pubmed	Polycystic Kidney Disease, Autosomal Dominant	GANAB ALG9	9.57e-05	7	75	2	20301424
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH2 DNAH9	9.57e-05	7	75	2	31178125
Pubmed	Role of ω-hydroxylase in adenosine-mediated aortic response through MAP kinase using A2A-receptor knockout mice.	CYP4F8 CYP4F12	9.57e-05	7	75	2	22160543
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	THADA VPS13C ALG9 PEX5 MRPL38 HACD2 BIRC6 SOD2	1.60e-04	719	75	8	35337019
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	URB1 ACLY VPS13C DNAH2 NARS1 BIRC6 PLS1 SYMPK	1.87e-04	736	75	8	29676528
Pubmed	Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.	AKR1A1 SOD2	2.04e-04	10	75	2	16543247
Pubmed	PEX19 is a predominantly cytosolic chaperone and import receptor for class 1 peroxisomal membrane proteins.	PXMP4 PEX5	2.04e-04	10	75	2	14709540
Pubmed	Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.	AKR1A1 SOD2	2.04e-04	10	75	2	17149600
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	PIGT VWA8 ACLY TUBGCP3 LSS THOC5 SYMPK	2.08e-04	560	75	7	35241646
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	EDEM3 URB1 PIGT WASHC4 VWA8 TUBGCP3 XPO4 UGGT2	2.21e-04	754	75	8	33060197
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	PIGT LMF1 SLC4A7 GANAB VWA8 ACLY UGGT2 LSS HACD2 CLSTN1 SOD2	2.70e-04	1451	75	11	30550785
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	GANAB WASHC4 ACLY PAFAH1B2 NARS1 PEX5 OGFOD1 QRICH1 BIRC6 PLS1 YARS1	2.77e-04	1455	75	11	22863883
Pubmed	EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.	EDEM3 ATG2B UGGT2 RNF139	3.18e-04	150	75	4	32423001
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PITPNM2 THADA LMF1 RHBDF2 VPS13C TTC21B LSS ATP8B1 CYB5D1 CAMTA1 INVS	3.37e-04	1489	75	11	28611215
Pubmed	Sox2-Evf2 lncRNA-mediated mechanisms of chromosome topological control in developing forebrain.	AKR1B10 AKR1B15	3.52e-04	13	75	2	33593819
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	EDEM3 URB1 ACLY XPO4 UGGT2	3.86e-04	285	75	5	32838362
Pubmed	Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.	SLC4A7 PIK3R1 PEX5 MTMR1	4.07e-04	160	75	4	31678930
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	MRPL38 ZFC3H1 BIRC6 THOC5	4.36e-04	163	75	4	22113938
Pubmed	Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs.	URB1 PIGT HACD2 RNF139 BIRC6	4.58e-04	296	75	5	34186245
Pubmed	Global landscape of HIV-human protein complexes.	ANKRD13A PTK2B EDEM3 GANAB XPO4 PLS1	4.67e-04	457	75	6	22190034
Pubmed	Molecular cloning of murine STAP-1, the stem-cell-specific adaptor protein containing PH and SH2 domains.	PTK2B PIK3R1	4.73e-04	15	75	2	10679268
Pubmed	FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.	PIGT SLC4A7 GANAB ALG9 UGGT2 HACD2	5.29e-04	468	75	6	31056421
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	ANKRD13A THADA ACLY TUBGCP3 XPO4 BIRC6 YARS1	5.43e-04	657	75	7	36180527
Pubmed	Defective transcription initiation causes postnatal growth failure in a mouse model of nucleotide excision repair (NER) progeria.	CYP4F8 PIK3R1 CYP4F12	6.05e-04	76	75	3	22323595
Pubmed	Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways.	PTK2B PIK3R1	6.11e-04	17	75	2	12960231
Pubmed	Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.	PTK2B PIK3R1	6.11e-04	17	75	2	18453587
Pubmed	Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy.	TTC21B INVS	6.87e-04	18	75	2	21068128
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	THADA TTC21B ZFC3H1 CLSTN1 BIRC6 THOC5	6.94e-04	493	75	6	15368895
Pubmed	A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III.	PIGT VWA8 PIK3R1 XPO4 HACD2 BIRC6 PLS1	7.00e-04	686	75	7	28380382
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	ANKRD13A THADA MTMR1 MRPL38 THOC5 YARS1 SYMPK	7.19e-04	689	75	7	36543142
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	PIGT SLC4A7 WASHC4 PIK3R1 VPS13C ATG2B	7.78e-04	504	75	6	34432599
Pubmed	Global Interactome Mapping of Mitochondrial Intermembrane Space Proteases Identifies a Novel Function for HTRA2.	PIGT VWA8 PIK3R1 SUPV3L1 QRICH1 BIRC6	8.70e-04	515	75	6	31617661
Pubmed	Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.	PIGT GANAB ACLY ATG2B NARS1 MTMR1 XPO4 MRPL38	8.87e-04	931	75	8	27432908
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	GANAB PAFAH1B2 NARS1 BIRC6 YARS1	9.01e-04	344	75	5	30333137
Pubmed	Nephronophthisis-Related Ciliopathies	TTC21B INVS	9.38e-04	21	75	2	27336129
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PITPNM2 PTK2B SNPH PEBP1 ACLY AKR1B10 PAFAH1B2 NARS1 MTMR1 YARS1	9.81e-04	1431	75	10	37142655
Pubmed	Identification of Modifier Genes in a Mouse Model of Gaucher Disease.	MAMDC2 THOC5	1.03e-03	22	75	2	27568557
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	GANAB ACLY PAFAH1B2 DBR1 YARS1	1.10e-03	360	75	5	33111431
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	PIGT SLC4A7 GANAB WASHC4 ALG9 LSS ZFC3H1 SOD2 SYMPK	1.11e-03	1203	75	9	29180619
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	GANAB PEBP1 ACLY PAFAH1B2 YARS1 SOD2	1.24e-03	552	75	6	36293380
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	IGBP1 SLC4A7 VPS13C ALG9 ATG2B HACD2	1.44e-03	568	75	6	37774976
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	IGBP1 THADA SLC4A7 PEBP1 VPS13C PEX5 BIRC6	1.44e-03	777	75	7	35844135
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	URB1 VWA8 ZFC3H1	1.54e-03	105	75	3	9628581
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	GANAB PEBP1 ACLY VPS13C PAFAH1B2 NARS1 AKR1A1 PLS1	1.55e-03	1016	75	8	19056867
Pubmed	Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease.	ACLY NARS1	1.56e-03	27	75	2	36266428
Pubmed	Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development.	DHH AKR1B10	1.67e-03	28	75	2	21820362
Pubmed	Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.	GIPR AKR1B10	1.67e-03	28	75	2	28911199
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	CYP4F8 SLC4A7 GANAB PEBP1 ACLY PIK3R1 XPO4 YARS1 SOD2	1.75e-03	1284	75	9	17353931
Pubmed	An evaluation of the assembly of an approximately 15-Mb region on human chromosome 13q32-q33 linked to bipolar disorder and schizophrenia.	NALCN UGGT2	1.79e-03	29	75	2	11991713
Pubmed	A mitochondrial protein compendium elucidates complex I disease biology.	SNPH MPV17L2 ACLY SUPV3L1 AKR1B10 NARS1 MRPL38 SOD2	1.87e-03	1047	75	8	18614015
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	IGBP1 GANAB PIK3R1 MTMR1 XPO4 BIRC6 PTPRT SYMPK	1.89e-03	1049	75	8	27880917
Interaction	DBNL interactions	CYP4F8 GANAB ACLY PLS1 INVS SSUH2 SYMPK	6.85e-06	190	75	7	int:DBNL
Interaction	AKR1B10 interactions	PIGT AKR1B10 AKR1B15 SSUH2	1.61e-05	41	75	4	int:AKR1B10
Cytoband	18q21.31	NARS1 ATP8B1	3.11e-04	16	75	2	18q21.31
Cytoband	12q24.11	ANKRD13A WASHC4	1.35e-03	33	75	2	12q24.11
Cytoband	11q23	ALG9 PAFAH1B2	1.60e-03	36	75	2	11q23
Cytoband	7q33	AKR1B10 AKR1B15	2.07e-03	41	75	2	7q33
Cytoband	19p13.1	CYP4F8 CYP4F12	2.83e-03	48	75	2	19p13.1
GeneFamily	Aldo-keto reductases	AKR1B10 AKR1B15 AKR1A1	7.33e-06	15	47	3	399
GeneFamily	Dyneins, axonemal	DNAH2 DNAH9	8.77e-04	17	47	2	536
GeneFamily	Phosphoinositide phosphatases	MTMR1 INPP4B	3.12e-03	32	47	2	1079
GeneFamily	Autophagy related	ATG9B ATG2B	3.32e-03	33	47	2	1022
GeneFamily	Cytochrome P450 family 4	CYP4F8 CYP4F12	3.94e-03	36	47	2	1003
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	URB1 VPS13C XPO4 HACD2 BIRC6 INVS	8.54e-07	191	75	6	9454f642c3621370fa23640b631301346b300950
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHG7 DNAH2 DNAH9 PTPRT SSUH2	9.83e-06	169	75	5	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	GIPR PLEKHG7 DNAH2 DNAH9 PTPRT	1.52e-05	185	75	5	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	15-Airway-Epithelial-Multiciliated_cell\|Airway / Age, Tissue, Lineage and Cell class	GIPR ATG9B DNAH2 DNAH9 PTPRT	1.52e-05	185	75	5	0998b6bf44287eebbf39249fff23fc3689e44c4e
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GIPR PLEKHG7 DNAH2 DNAH9 PTPRT	1.60e-05	187	75	5	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	RA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	SLC4A7 PRMT9 UGGT2 CYB5D1 SOD2	1.69e-05	189	75	5	b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
Drug	zopolrestat	AKR1B10 AKR1B15 AKR1A1 SOD2	1.80e-06	27	75	4	CID000001613
Drug	N(omega)-hydroxy-L-arginine	NALCN AKR1B10 AKR1A1 RNF139 SOD2	3.99e-06	72	75	5	CID000123895
Drug	Daunorubicin	PIK3R1 AKR1B10 SMPD1 AKR1A1 PLK3 INPP4B SOD2	7.21e-06	216	75	7	ctd:D003630
Drug	AL-4114	AKR1B10 AKR1A1 SOD2	7.39e-06	12	75	3	CID000164424
Drug	naphthalene-1,2-dihydrodiol	CYP4F8 AKR1B10 CYP4F12 AKR1A1	1.46e-05	45	75	4	CID000000362
Drug	oregon green 488 carboxylate	AKR1B10 PEX5 AKR1A1 SOD2	1.60e-05	46	75	4	CID005289081
Drug	daunorubicinol	AKR1B10 AKR1A1	3.21e-05	3	75	2	ctd:C000847
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A	SLC4A7 PIK3R1 TUBGCP3 MTMR1 DBR1 SOD2	4.77e-05	197	75	6	2116_DN
Drug	Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	THADA RHBDF2 TUBGCP3 PEX5 SOD2 INVS	4.90e-05	198	75	6	7384_DN
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A	VWA8 PIK3R1 PAFAH1B2 TUBGCP3 MTMR1 UGGT2	4.90e-05	198	75	6	5338_DN
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; HL60; HT_HG-U133A	LMF1 PIK3R1 PEX5 LSS SMPD1 PLS1	5.04e-05	199	75	6	2713_DN
Drug	benzene dihydrodiol	AKR1B10 AKR1A1 SYMPK	5.05e-05	22	75	3	CID000000418
Drug	AC1L1F9Q	CYP4F8 OXER1 PIK3R1 PEX5 CYP4F12 SOD2	5.33e-05	201	75	6	CID000003144
Drug	naphthalene	CYP4F8 AKR1B10 CYP4F12 AKR1A1 PLS1	5.41e-05	123	75	5	CID000000931
Drug	5-Isothiocyanatoalrestatin	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID000124861
Drug	M7HEQ	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID006452329
Drug	NAP-HEX-Q	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID005487149
Drug	WF-2421	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID000195567
Drug	matteuorienate A	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID000190958
Drug	5-azidoalrestatin	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID000128442
Drug	5-(3-Thienyl)tetrazol-1-yl)acetic acid	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID003035658
Drug	FR-62765	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID000128354
Drug	danshenol B	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID003083515
Drug	iodomethanesulfonamide	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID000519939
Drug	salviaflaside	AKR1B10 AKR1A1	6.40e-05	4	75	2	CID006438919
Drug	kolaviron	AKR1B10 AKR1A1 SOD2	6.61e-05	24	75	3	CID000155169
Drug	9,10-phenanthrenequinone	AKR1B10 AKR1A1 SOD2	7.49e-05	25	75	3	ctd:C005399
Drug	2,3-hexanedione	AKR1B10 AKR1A1	1.06e-04	5	75	2	ctd:C043231
Drug	AD-5467	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000197383
Drug	M79175	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000115090
Drug	xanthone-2	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID005384285
Drug	AC1L4VGL	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000213726
Drug	4-chloro-3-nitrobenzaldehyde	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000085505
Drug	ICI 105552	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000133677
Drug	2-(2,3,6-Trihydroxy-4-carboxyphenyl)ellagic acid	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID006918808
Drug	ICI 222155	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000195716
Drug	DN-108	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000183791
Drug	BAL-ARI8	AKR1B10 AKR1A1	1.06e-04	5	75	2	CID000130098
Drug	p225	AKR1B10 AKR1A1	1.59e-04	6	75	2	CID000014589
Drug	ICI 215918	AKR1B10 AKR1A1	1.59e-04	6	75	2	CID000129688
Drug	AC1L28UN	AKR1B10 AKR1A1	1.59e-04	6	75	2	CID000068017
Drug	M16287	AKR1B10 AKR1A1	1.59e-04	6	75	2	CID000188399
Drug	ADN-138	AKR1B10 AKR1A1	1.59e-04	6	75	2	CID000127323
Drug	BAPSG	AKR1B10 AKR1A1	1.59e-04	6	75	2	CID000130998
Drug	capillarisin	AKR1B10 AKR1A1	1.59e-04	6	75	2	CID005281342
Disease	Skin Abnormalities	SUPV3L1 LSS SOD2	4.43e-06	13	75	3	C0037268
Disease	urinary potassium to creatinine ratio	GIPR SLC4A7	9.50e-05	6	75	2	EFO_0009882
Disease	NEPHRONOPHTHISIS 2	TTC21B INVS	1.77e-04	8	75	2	C1865872
Disease	symmetrical dimethylarginine measurement	AKR1B10 AKR1B15	2.27e-04	9	75	2	EFO_0006523
Disease	Polycystic Kidney, Autosomal Dominant	GANAB ALG9	2.27e-04	9	75	2	C0085413
Disease	Papillary Renal Cell Carcinoma	PEBP1 RNF139 INPP4B SOD2	3.24e-04	128	75	4	C1306837
Disease	Malignant Neoplasms	PIK3R1 AKR1B10 BIRC6 SOD2	3.24e-04	128	75	4	C0006826
Disease	Renal Cell Carcinoma	PEBP1 RNF139 INPP4B SOD2	3.24e-04	128	75	4	C0007134
Disease	Sarcomatoid Renal Cell Carcinoma	PEBP1 RNF139 INPP4B SOD2	3.24e-04	128	75	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PEBP1 RNF139 INPP4B SOD2	3.24e-04	128	75	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PEBP1 RNF139 INPP4B SOD2	3.24e-04	128	75	4	C1266044
Disease	Nephronophthisis	TTC21B INVS	4.88e-04	13	75	2	C0687120
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	PEBP1 RNF139 INPP4B SOD2	5.60e-04	148	75	4	C0279702
Disease	Benign Neoplasm	AKR1B10 BIRC6 SOD2	7.02e-04	68	75	3	C0086692
Disease	Neoplasms	AKR1B10 BIRC6 SOD2	7.02e-04	68	75	3	C0027651
Disease	Necrotizing Enterocolitis	AKR1A1 SOD2	8.46e-04	17	75	2	C0520459
Disease	interleukin 18 measurement	PIK3R1 BIRC6 PTPRT	9.70e-04	76	75	3	EFO_0004581
Disease	acetone measurement	GIPR VWA8	1.06e-03	19	75	2	EFO_0010989
Disease	Pancreatic carcinoma	INPP4B SOD2	1.06e-03	19	75	2	C0235974
Disease	Alopecia	SUPV3L1 LSS	1.06e-03	19	75	2	C0002170
Disease	heart failure	PXMP4 LMF1 AKR1A1 SYMPK	1.28e-03	185	75	4	EFO_0003144
Disease	hyperglycemia (biomarker_via_orthology)	GIPR HCRTR2	1.30e-03	21	75	2	DOID:4195 (biomarker_via_orthology)
Disease	X-12063 measurement	EDEM3 TUBGCP3 XPO4 INPP4B	1.31e-03	186	75	4	EFO_0021283
Disease	glioma	LMF1 CYP4F12	1.42e-03	22	75	2	EFO_0005543
Disease	Kidney Diseases	TTC21B SMPD1 SOD2	1.48e-03	88	75	3	C0022658
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	MTMR1 YARS1	1.70e-03	24	75	2	DOID:10595 (implicated_via_orthology)
Disease	glucose tolerance test	GIPR VPS13C	2.15e-03	27	75	2	EFO_0004307
Disease	Amyotrophic Lateral Sclerosis With Dementia	DBR1 SOD2	2.48e-03	29	75	2	C0393554

Protein segments in the cluster

Peptide	Gene	Start	Entry
LYLWYTGEPNDALRH	TTC21B	1031	Q7Z4L5
YWLLQNPDIVLVHYL	CAMTA1	166	Q9Y6Y1
IPFWYHMYLDEEIRL	PRMT9	786	Q6P2P2
LWHSYELLVEYDLPA	BIRC6	3501	Q9NR09
AIPHWQLLYRARETY	SMPD1	531	P17405
IRSYAYLLLHAWPAA	ALG9	111	Q9H6U8
KLSYLDVYLIHWPQG	AKR1B10	101	O60218
YTWLLVEGVYLHSLL	GIPR	231	P48546
ASYEEVLHLLRYRNW	CLSTN1	766	O94985
LESIWEILHRYLPYN	CYB5D1	156	Q6P9G0
HLWSCALDYRPLYLP	ATG2B	1241	Q96BY7
YLQRLLLVHGRWSYI	ATP8B1	931	O43520
YPVASLSHLELWVNY	MTMR1	586	Q13613
DLYYVRFTEWLHEVL	QRICH1	571	Q2TAL8
SLPWILNEEGHYIYV	MAMDC2	41	Q7Z304
YPLHLLVWKNDYRQL	ANKRD13A	11	Q8IZ07
QDHEILYDWINPTYL	OGFOD1	261	Q8N543
LHYWYLSLDRLFPAS	MPV17L2	76	Q567V2
HPREDWYEQLYPLIL	INPP4B	571	O15327
DYIFTTEAHLLPLWL	EDEM3	486	Q9BZQ6
LSPEELLLRWVNYHL	PLS1	266	Q14651
EYYLLHLQRWIDISL	IGBP1	191	P78318
GLHRYVWLVYEQDRP	PEBP1	116	P30086
LRDWLRYTPAYAHLV	PEX5	426	P50542
YTPHSWLLRVVYALL	LSS	286	P48449
WLLRVVYALLNLYEH	LSS	291	P48449
LVSHPVLSFLYRWIY	TUBGCP3	421	Q96CW5
SIPHQYWLTLQYLLK	PIK3R1	231	P27986
VVRHWQDLGYLIIYV	PITPNM2	1136	Q9BZ72
PLRVDYYLLHETWRF	OXER1	146	Q8TDS5
IVQHLQYIGWPAYRD	PTPRT	1331	O14522
DEEFLRYLWREYLHP	HCRTR2	36	O43614
HWYSRLLYRLAEELL	DHH	381	O43323
LLNHLPYLIKWARYT	HACD2	156	Q6Y1H2
GLSWVLYNLARHPEY	CYP4F8	336	P98187
GLSWVLYNLARHPEY	CYP4F12	336	Q9HCS2
YWDIQVFYREALHIP	ATG9B	306	Q674R7
PDYLEYDIEWLTILR	DBR1	276	Q9UK59
WDLIRLYLHESNRVY	DNAH9	2701	Q9NYC9
LHVEAEWRYDLQIRY	PTK2B	121	Q14289
YWERLLFETPHYVVN	DNAH2	646	Q9P225
YEIWRELFSPLHALN	PAFAH1B2	56	P68402
YDNLFRTPLHWAALL	INVS	251	Q9Y283
ILPVLLSYVLWHHYA	RNF139	401	Q8WU17
PWELLELRVSYYENV	YARS1	86	P54577
RLLEYVYTHWEHPLD	THADA	391	Q6YHU6
KHQPDLIYLRYVPLW	SLC4A7	1066	Q9Y6M7
RLDLPEDFHYSYELW	STRIP2	801	Q9ULQ0
WILNRYHIRDVCLYP	NARS1	526	O43776
WYTLLYQAHREGIPV	GANAB	711	Q14697
VHDVLDLYLWLSYRF	SUPV3L1	631	Q8IYB8
EPKSYWSRHYIVDLL	SNPH	416	O15079
YEIIRDYSLLTWILH	URB1	1846	O60287
IELIPLTEVHYWYQG	SSUH2	331	Q9Y2M2
QGLYRHPWDDISYVL	ACLY	1081	P53396
KLSYLDVYLIHWPQG	AKR1B15	101	C9JRZ8
DLQLEYLDLYLMHWP	AKR1A1	101	P14550
WKARHTLLEPEVRYY	PLK3	151	Q9H4B4
YEDIHWLILVTGYLL	XPO4	536	Q9C0E2
LEPDAEYLHWLLTNI	MRPL38	226	Q96DV4
LDTVPWYLRLYVHTL	PIGT	386	Q969N2
EDWDVAYIIHLYPSL	VPS13C	2656	Q709C8
LIPLLGIDVWEHAYY	SOD2	176	P04179
IPRDHPYIQYNVLWE	SYMPK	216	Q92797
RRLYWDVTLENYSHL	ZNF41	91	P51814
LYWHRAVFPIYLDDV	WASHC4	606	Q2M389
YLQTHEYLLDVDLWR	PLEKHG7	321	Q6ZR37
YELLRGWRPYEIHSV	STK32B	216	Q9NY57
LNSHIWEYTYVLDIR	UGGT2	426	Q9NYU1
SDYVLELGHPYLWVQ	THOC5	431	Q13769
AIQWLYPYSILLGHE	VWA8	336	A3KMH1
PDQFYRLWLSLFLHA	RHBDF2	651	Q6PJF5
LVLWLFEYHRSTLQP	PXMP4	166	Q9Y6I8
WLAYIHLIEFNILPS	ZFC3H1	1526	O60293
RPCLISPYHYRLDWL	LMF1	451	Q96S06
HQLYDLLGLVTYLDW	NALCN	876	Q8IZF0